Since ROS regulates the OGDH and AMP-activated protein kinase (AMPK) [8,37,38], we evaluate the total-OGDH, phospho-, and total-AMPK levels at 4 h of treatment in BC cells. The gene discussed is OGDH; the disease is breast cancer.